by Max Brantley
SAN FRANCISCO, April 13, 2017 —McKesson Corporation issues the following statement in response to the Arkansas Department of Correction’s planned executions:
The Arkansas Department of Correction intentionally sought to circumvent McKesson’s policies to procure Pfizer’s vecuronium bromide under the auspices that it would be used for medical purposes in ADC’s health facility. Upon learning that ADC was potentially holding the product for lethal injection purposes, McKesson immediately requested and was assured by ADC that the product would be returned. McKesson issued a full refund to ADC, and made several additional requests for the product, but the product was never returned.
As of April 13, 2017, ADC continues to hold McKesson’s product despite the company’s repeated attempts to compel ADC to either return the product or assure us in writing that the products will not be used for lethal injection purposes. McKesson is considering all possible means by which to secure the return of the product, up to and including legal action.